Sr Manager, Sustainability at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • 8+ years of relevant experience with a bachelor’s degree in environmental science, Sustainability, Climate Science, Engineering, Business, or a related field OR 6+ years of relevant experience with a Master’s degree
  • Deep expertise in climate risk assessment methodologies and frameworks (TCFD strongly preferred)
  • Demonstrated experience managing corporate sustainability reporting and a strong understanding of leading ESG standards (e.g., GRI, SASB, IFRS Sustainability Disclosure Standards)
  • Proven ability in data analysis and translating complex information into clear, actionable insights for a business audience
  • Experience designing (incomplete in description, but implied as relevant to climate/sustainability strategies)

Responsibilities

  • Lead the management of physical and transitional climate-related risks and opportunities across Gilead's operations, value chain, and portfolio in alignment with frameworks such as TCFD
  • Develop, champion, and implement a long-term climate adaptation and resilience strategy to mitigate identified risks, protect assets and supply chain, and support communities
  • Support the end-to-end process for corporate sustainability reporting, ensuring adherence with evolving global disclosure standards and regulations (e.g., CSRD, California climate laws, CDP)
  • Enhance and maintain a centralized, auditable system for managing all sustainability-related policies, procedures, data, and compliance documentation, ensuring data integrity and version control
  • Perform in-depth analysis of climate and sustainability data to generate actionable insights, track performance against targets, identify emerging trends, and inform strategic planning; prepare and present findings to stakeholders
  • Serve as a subject matter expert on climate risk, partnering closely with teams including Enterprise Risk Management, Finance, Legal, and Supply Chain to embed climate considerations into business strategy and processes

Skills

Climate Strategy
Sustainability Reporting
Climate Risk Management
Resilience Framework
Data Analysis
Stakeholder Communication
Environmental Stewardship

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI